Krystexxa 8 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26F9MK5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,043
Award facts
- Contract value 100% obligated
- $39,043.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,043.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Krystexxa 8 mg/ml vials, with a completion date of February 12, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting framework.
Quick answers
Who was awarded contract SPE2DR26F9MK5?
SPE2DR26F9MK5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MK5 worth?
The government has obligated $39,043 on SPE2DR26F9MK5.
Is contract SPE2DR26F9MK5 an order under another contract?
Yes. SPE2DR26F9MK5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MK5 competed?
The extent of competition for SPE2DR26F9MK5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award